SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems

Daniel Blanco-Melo; Benjamin E. Nilsson-Payant; Wen-Chun Liu; Rasmus Møller; Maryline Panis; David Sachs; Randy A. Albrecht; Benjamin R. tenOever

doi:10.1101/2020.03.24.004655

New Results

SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems

Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen-Chun Liu, Rasmus Møller, Maryline Panis, David Sachs, Randy A. Albrecht, Benjamin R. tenOever

doi: https://doi.org/10.1101/2020.03.24.004655

Daniel Blanco-Melo

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA

2Virus Engineering Center for Therapeutics and Research (VECToR), Icahn School of Medicine at Mount Sinai, New York, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Benjamin E. Nilsson-Payant

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA

2Virus Engineering Center for Therapeutics and Research (VECToR), Icahn School of Medicine at Mount Sinai, New York, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wen-Chun Liu

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA

3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rasmus Møller

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA

2Virus Engineering Center for Therapeutics and Research (VECToR), Icahn School of Medicine at Mount Sinai, New York, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maryline Panis

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA

2Virus Engineering Center for Therapeutics and Research (VECToR), Icahn School of Medicine at Mount Sinai, New York, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Sachs

4Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Randy A. Albrecht

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA

3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: benjamin.tenoever@mssm.edu

Benjamin R. tenOever

1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA

2Virus Engineering Center for Therapeutics and Research (VECToR), Icahn School of Medicine at Mount Sinai, New York, USA

3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: benjamin.tenoever@mssm.edu

Abstract
Full Text
Info/History
Metrics
Supplementary material
Preview PDF

Supplementary Table 1[supplements/004655_file02.xlsx]
Supplementary Table 2[supplements/004655_file03.xlsx]
Supplementary Table 3[supplements/004655_file04.xlsx]
Supplementary Table 4[supplements/004655_file05.xlsx]
Supplementary Table 5[supplements/004655_file06.xlsx]
Supplementary Table 6[supplements/004655_file07.xlsx]

View the discussion thread.

PreviousNext

Posted March 24, 2020.

Download PDF

Supplementary Material

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems

Message Subject (Your Name) has forwarded a page to you from bioRxiv

Message Body (Your Name) thought you would like to see this page from the bioRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems

Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen-Chun Liu, Rasmus Møller, Maryline Panis, David Sachs, Randy A. Albrecht, Benjamin R. tenOever

bioRxiv 2020.03.24.004655; doi: https://doi.org/10.1101/2020.03.24.004655

Share This Article:

Citation Tools

SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems

Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen-Chun Liu, Rasmus Møller, Maryline Panis, David Sachs, Randy A. Albrecht, Benjamin R. tenOever

bioRxiv 2020.03.24.004655; doi: https://doi.org/10.1101/2020.03.24.004655

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Microbiology

Subject Areas

All Articles

Animal Behavior and Cognition (2073)
Biochemistry (3934)
Bioengineering (2670)
Bioinformatics (12705)
Biophysics (5463)
Cancer Biology (4271)
Cell Biology (6132)
Clinical Trials (138)
Developmental Biology (3628)
Ecology (5797)
Epidemiology (2052)
Evolutionary Biology (8656)
Genetics (6550)
Genomics (8311)
Immunology (3476)
Microbiology (10306)
Molecular Biology (4087)
Neuroscience (23745)
Paleontology (171)
Pathology (662)
Pharmacology and Toxicology (1081)
Physiology (1618)
Plant Biology (3630)
Scientific Communication and Education (844)
Synthetic Biology (1137)
Systems Biology (3402)
Zoology (598)